Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for postpartum immunization in Rh and Coombs negative women with sensitization risk; trial status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Azidus Brasil | Conditions: Pregnancy; Fetomaternal Hemorrhage | Phase 3 | Status: SUSPENDED